(Q39316862)
Statements
1 reference
Genetic aspects of diseases of complement: an explosion (English)
2 references
Genetic aspects of diseases of complement: An explosion (English)
M. J. Polley
1 January 1975
1 reference
1 reference
58
1 reference
1
1 reference
105-111
1 reference
19
618
The “third component” a heat-stable factor of complement (English)
Whitehead
1925
20
1028
The action of ammonia on complement. The fourth component (English)
Gordon
1926
122
277
Isolation of β1F-globulin from human serum and its characterization as the fifth component of complement (English)
Nilsson
1965
117
983
Chromatographic resolution of the first component of human complement into three activities (English)
Lepow
1963
135
1003
C3 proactivator convertase and its mode of action (English)
Müller-Eberhard
0 references
118
733
The immune-adherence phenomenon. An immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis (English)
Nelson
1953
165
396
Immune adherence produced by the fourth component of complement (C4) (English)
Cooper
1969
282
354
A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5) (English)
Miller
1970
127
371
The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement (English)
Cochrane
1968
155
1122
Anaphylatoxin in its relation to the complement system (English)
Jensen
1967
129
1109
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum (English)
Bokisch
1969
124
397
Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin (English)
Austen
1966
165
508
Neutralization of sensitized virus by the fourth component of complement (English)
Daniels
1969
48
44a
A polypeptide derived from the second component of human complement (C2) which increases vascular permeability (English)
Klemperer
1969
134
1601
Blood coagulation initiation by a complement-mediated pathway (English)
Zimmerman
1971
180
1183
Complement-induced platelet protein alterations (English)
Zimmerman
1973
0 references
35
37
A biochemical abnormality in hereditary angioneurotic edema (English)
Donaldson
1963
148
957
Hereditary angioneurotic edema: two genetic variants (English)
Rosen
1965
49
1975
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection (English)
Alper
1970
137
424
The relationship of glycine-rich β-glycoprotein to factor B in the properdin system and to the cobra factor-building protein of human serum (English)
Alper
1973
45
880
Hereditary deficiency of the second component of complement (C2) in man (English)
Klemperer
1966
161
1149
Inherited C2 deficiency in man: lack of immunochemically detectable C2 protein in serum from deficient individuals (English)
Polley
1968
52
1601
C2 deficiency. Development of lupus erythematosus (English)
1973
2
1179
Homozygous deficiency of C3 in a patient with repeated infections (English)
Alper
1972
170
74
Genetically controlled total deficiency of the fourth component of complement in the guinea pig (English)
Ellman
1970
124
773
Deficiency of the sixth component of complement in rabbit with an inherited complement defect (English)
Rother
1966
137
1109
Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator (English)
Vallota
1973
0 references
120
279
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena (English)
Pillemer
1954
139
44
The role of properdin in the alternate method of complement activation (English)
Götze
1974
Identifiers
1 reference
1 reference